Westpac Banking Corp
WBC
ANZ Group Holdings Ltd
ANZ
Origin Energy Ltd
ORG
National Australia Bank Ltd
NAB
Telstra Group Ltd
TLS
Wilsons Reaffirms Their Buy Rating on Clarity Pharmaceuticals Ltd. (CU6)
Bell Potter Remains a Buy on Clarity Pharmaceuticals Ltd. (CU6)
Clarity Pharmaceuticals Price Target Raised to A$10.00/Share From A$4.00 by Bell Potter
Jefferies Sticks to Their Buy Rating for Clarity Pharmaceuticals Ltd. (CU6)